Background
Normal laboratory values (adult patients):
Calcium (Serum): 8.5 - 10.5 mg/dL (2.12 - 2.57 mmol/L )
Calcium (Ionized) Serum: 4.5 - 5.6 mg/dL (1.1-1.4 mmol/L)
Body Calcium:
99% in bone. 1% in ECF:
[50% in its free ionized form]
[40% complexed with albumin]
[10% complexed with anions such as phosphate.]
Less than 1% of the body's calcium is contained within the ECF, yet
this concentration is regulated carefully by the parathyroid hormone
and calcitonin. Parathyroid hormone is released by the
parathyroid gland in response to a low serum calcium level. It
increases resorption of bone (movement of Ca++ and PO4 out of the
bone); activates vitamin D, which increases the absorption of calcium
from the GIT; and simultaneously stimulates the kidneys to conserve
calcium and excrete phosphorus. Calcitonin is produced by the
thyroid gland when serum calcium levels are elevated (inhibits bone
resorption).
The ECF gains Ca++ from intestinal absorption and resorption from bones. It is lost from the ECF via secretion
into the GIT, urinary excretion, and deposition into bone.
Calcium is present in 3 different forms in the plasma: ionized, bound
and complexed. Only the ionized calcium is physiologically important.
The percentage of calcium that is ionized is affected by pH,
phosphorus, and albumin levels. The relationship between
ionized calcium and plasma pH is reciprocal (increase in pH decreases
percent of Ca++ ionized). Patients with alkalosis for example may
show signs of hypocalcemia despite a normal total calcium level.
Changes in albumin will affect total serum calcium without changing
the level of free calcium. (decreased albumin
--> decreased
total Ca++ -->
constant free Ca++)
Hypocalcemia
Signs and symptoms:
Numbness with tingling of
fingers, extremities and circumoral region
hyperactive reflexes,
muscle cramps,
carpopedal
spasm,
stridor,
tetany,
seizures.
Positive Trousseau's sign (carpal
spasm with BP cuff) and positive Chvostek's sign (contraction of
facial and eyelid muscles when facial nerve tapped). Cardiac
effects include decreased myocardial contractility and heart failure.
History and risk factors: 1) Decreased ionized calcium: alkalosis;
administration of large quantities of citrated blood (may bind
calcium); hemodilution (volume replacement etc.) 2) Increased calcium loss in body fluids:
certain diuretics. 3)
Decreased intestinal absorption:
decreased intake; impaired vitamin D metabolism (renal failure);
chronic diarrhea, post-gastrectomy. 4) Hypoparathyroidism:
congenital or acquired. 5) Hyperphosphatemia:
e.g. renal failure. When hypocalcemia persists, it is best to delay
calcium supplementation until the serum phosphate level is below 6
mg/dL to reduce the risk of metastatic calcification. 6) Hypomagnesemia
(decreased PTH action and release). Chronic alcoholism; acute
pancreatitis. Hypocalcemia is difficult to correct without
first normalizing the serum magnesium concentration.
Diagnostic tests:
-Total serum calcium may be less than
8.5 mg/dl. Serum calcium levels should be evaluated with
serum albumin. For every 1.0 mg/dL drop in serum albumin, there
is a 0.8 - 1.0 mg/dL drop in the total calcium level.
-Ionized calcium will be less than 4.2
mg/dL. Symptoms of hypocalcemia usually occur when ionized levels
fall to <2.5 mg/dL.
-Parathyroid hormone: decreased levels
occur in hypoparathyroidism.
-Magnesium and phosphorus levels:
may be checked to indentify potential causes of hypocalcemia.
Treatment should be based on:
(1) Symptoms present: Paresthesias, tetany, carpopedal spasm,
seizures
(2) Signs: Chvosek's or Trousseau's signs, impaired cardiac
contractility, prolongation of the QT interval, bradycardia).
(3) Absolute level of calcium
(4) Rate of decrease (e.g. acute versus chronic decrease).
The therapeutic approach and management of hypocalcemia depends
largely on the severity of symptoms and the underlying cause.
In patients with asymptomatic hypocalcemia, it is important to verify
with repeat measurement (ionized or total calcium corrected for serum
albumin).
|
Calcium Supplementation Based on Age
Source:
https://ods.od.nih.gov/factsheets/Calcium-QuickFacts/
The amount of calcium you need each day depends on
your age. Average daily recommended amounts are listed
below in milligrams (mg):
Birth to 6 months |
200 mg |
Infants 7–12 months |
260 mg |
Children 1–3 years |
700 mg |
Children 4-8 years |
1,000 mg |
Children 9–13 years |
1,300 mg |
Teens 14–18 years |
1,300 mg |
Adults 19–50 years |
1,000 mg |
Adult men 51–70 years |
1,000 mg |
Adult women 51–70 years |
1,200 mg |
Adults 71 years and older |
1,200 mg |
Pregnant and breastfeeding teens |
1,300 mg |
Pregnant and breastfeeding
adults |
1,000 mg |
Upper limits - calcium: Source:
https://ods.od.nih.gov/factsheets/Calcium-QuickFacts/The safe upper
limits for calcium are listed below. Most people do not get amounts
above the upper limits from food alone; excess intakes usually come
from the use of calcium supplements. Surveys show that some older
women in the United States probably get amounts somewhat above the
upper limit since the use of calcium supplements is common among
these women.
Advertisement
Birth to 6 months |
1,000 mg |
Infants 7-12 months |
1,500 mg |
Children 1-8 years |
2,500 mg |
Children 9-18 years |
3,000 mg |
Adults 19-50 years |
2,500 mg |
Adults 51 years and older |
2,000 mg |
Pregnant and breastfeeding teens |
3,000 mg |
Pregnant and breastfeeding
adults |
2,500 mg |
|
Vitamin D: Reference Intakes / RDA
Source: https://ods.od.nih.gov/factsheets/vitamind/Intake
reference values for vitamin D and other nutrients are provided in the Dietary
Reference Intakes (DRIs) developed by the Food and Nutrition Board (FNB) at the
Institute of Medicine of The National Academies (formerly National Academy of
Sciences). DRI is the general term for a set of reference values used to plan
and assess nutrient intakes of healthy people. These values, which vary by age
and gender, include:
- Recommended Dietary Allowance (RDA): average daily level of intake
sufficient to meet the nutrient requirements of nearly all (97%–98%) healthy
people.
- Adequate Intake (AI): established when evidence is insufficient to
develop an RDA and is set at a level assumed to ensure nutritional adequacy.
- Tolerable Upper Intake Level (UL): maximum daily intake unlikely to
cause adverse health effects.
The FNB established an RDA for vitamin D representing a daily intake that is
sufficient to maintain bone health and normal calcium metabolism in healthy
people. RDAs for vitamin D are listed in both International Units (IUs) and
micrograms (mcg); the biological activity of 40 IU is equal to 1 mcg (Table 2).
Even though sunlight may be a major source of vitamin D for some, the vitamin D
RDAs are set on the basis of minimal sun exposure.
Table 2: Recommended Dietary
Allowances (RDAs) for Vitamin D
Age |
Male |
Female |
Pregnancy |
Lactation |
0–12 months* |
400 IU
(10 mcg) |
400 IU
(10 mcg) |
|
|
1–13 years |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
|
|
14–18 years |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
19–50 years |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
51–70 years |
600 IU
(15 mcg) |
600 IU
(15 mcg) |
|
|
>70 years |
800 IU
(20 mcg) |
800 IU
(20 mcg) |
|
|
Health Risks from Excessive Vitamin D
Vitamin D toxicity can cause non-specific symptoms such as anorexia, weight
loss, polyuria, and heart arrhythmias. More seriously, it can also raise blood
levels of calcium which leads to vascular and tissue calcification, with
subsequent damage to the heart, blood vessels, and kidneys [1].
The use of supplements of both calcium (1,000 mg/day) and vitamin D (400 IU) by
postmenopausal women was associated with a 17% increase in the risk of kidney
stones over 7 years in the Women's Health Initiative. A serum 25(OH)D
concentration consistently >500 nmol/L (>200 ng/mL) is considered to be
potentially toxic.
Excessive sun exposure does not result in vitamin D toxicity because the
sustained heat on the skin is thought to photodegrade previtamin D3
and vitamin D3 as it is formed. In addition, thermal activation of
previtamin D3 in the skin gives rise to various non-vitamin D forms
that limit formation of vitamin D3 itself. Some vitamin D3
is also converted to nonactive forms [1].
Intakes of vitamin D from food that are high enough to cause toxicity are very
unlikely. Toxicity is much more likely to occur from high intakes of dietary
supplements containing vitamin D.
Long-term intakes above the UL increase the risk of adverse health effects [1]
(Table 4). Most reports suggest a toxicity threshold for vitamin D of 10,000 to
40,000 IU/day and serum 25(OH)D levels of 500–600 nmol/L (200–240 ng/mL). While
symptoms of toxicity are unlikely at daily intakes below 10,000 IU/day, the FNB
pointed to emerging science from national survey data, observational studies,
and clinical trials suggesting that even lower vitamin D intakes and serum
25(OH)D levels might have adverse health effects over time. The FNB concluded
that serum 25(OH)D levels above approximately 125–150 nmol/L (50–60 ng/mL)
should be avoided, as even lower serum levels (approximately 75–120 nmol/L or
30–48 ng/mL) are associated with increases in all-cause mortality, greater risk
of cancer at some sites like the pancreas, greater risk of cardiovascular
events, and more falls and fractures among the elderly. The FNB committee cited
research which found that vitamin D intakes of 5,000 IU/day achieved serum
25(OH)D concentrations between 100–150 nmol/L (40–60 ng/mL), but no greater.
Applying an uncertainty factor of 20% to this intake value gave a UL of 4,000 IU
which the FNB applied to children aged 9 and older, with corresponding lower
amounts for younger children.
Table 4: Tolerable Upper Intake
Levels (ULs) for Vitamin D [1]
Age |
Male |
Female |
Pregnancy |
Lactation
|
0–6 months |
1,000 IU
(25 mcg) |
1,000 IU
(25 mcg) |
|
|
7–12 months |
1,500 IU
(38 mcg) |
1,500 IU
(38 mcg) |
|
|
1–3 years |
2,500 IU
(63 mcg) |
2,500 IU
(63 mcg) |
|
|
4–8 years |
3,000 IU
(75 mcg) |
3,000 IU
(75 mcg) |
|
|
9
years |
4,000 IU
(100 mcg) |
4,000 IU
(100 mcg) |
4,000 IU
(100 mcg) |
4,000 IU
(100 mcg) |
1. Institute of Medicine, Food and Nutrition
Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC:
National Academy Press, 2010. |